What is Beam Therapeutics's current ratio?

Beam Therapeutics (BEAM) reported current ratio of 17× in Q1 2026.

How has Beam Therapeutics's current ratio changed year-over-year?

Beam Therapeutics's current ratio increased by 92.8% year-over-year, from 8.8× to 17×.

What is the long-term trend for Beam Therapeutics's current ratio?

Over 5 years (2020 to 2025), Beam Therapeutics's current ratio has grown at a 34.1% compound annual growth rate (CAGR), from 3× to 13.1×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.

Beam Therapeutics BEAM Current ratio

Current ratio at other companies

Vertex PharmaceuticalsVRTX

3×+0.4×

Arrowhead ResearchARWR

6.2×+1.1×

CRISPR TherapeuticsCRSP

18×+2.3×

Cogent Biosciences, Inc.COGT

15.1×+10.0×

PTC TherapeuticsPTCT

2.4×-1.5×

BridgeBio PharmaBBIO

1.5×-3.0×

Other financials

Income statement

See full

Revenue$31.7M+325%

Operating income-$107.2M+10.1%

Net income-$94.3M+12.9%

EPS (diluted)-$0.91+26.0%

Balance sheet

See full

Cash & equivalents$288.3M-45.4%

Total debt$250.8M+58.6%

Total equity$1.2B+3.1%

Total assets$1.5B+0.9%

Cash flow

See full

Operating cash flow-$128.5M-23.7%

CapEx$2.2M-27.2%

Free cash flow-$130.7M-22.2%

Valuation

See full

Market cap$3.51B+24.5%

Enterprise value$3.47B+51.2%

P/S21.4×-23.0×

Profitability

See full

Operating margin-226.6%-90.5pp

Net margin-742.7%—

FCF margin-234%-86.6pp

Returns & leverage

See full

Return on equity-47.1%—

Debt / equity0.2×+0.1×

Where this comes from

Calculated from Beam Therapeutics’s reported figures.

total current assets/total current liabilities=17×

Based on the most recent quarter.

The official record: Beam Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Beam Therapeutics's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Beam Therapeutics's current ratio?: Beam Therapeutics (BEAM) reported current ratio of 17× in Q1 2026.
How has Beam Therapeutics's current ratio changed year-over-year?: Beam Therapeutics's current ratio increased by 92.8% year-over-year, from 8.8× to 17×.
What is the long-term trend for Beam Therapeutics's current ratio?: Over 5 years (2020 to 2025), Beam Therapeutics's current ratio has grown at a 34.1% compound annual growth rate (CAGR), from 3× to 13.1×.
What does current ratio mean?: Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.